These are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information. For more information, please see our FAQs.
Using the SARS Infection Transcriptional Signature to Identify Potential Treatments for Covid-19
preprintsubmitted on 19.05.2020, 12:39 and posted on 20.05.2020, 09:40 by Richard Killick, Clive Ballard, Patrick Doherty, Gareth Williams
Gene expression data associated with viral infection of human cell lines is harnessed to define a conserved viral response signature. Drugs that tend to drive gene expression in the direction of the cellular viral response are significantly enriched for those with established antiviral activity. Transcription therefore facilitates a simple and effective filtering of candidate drugs to be put forward for bioassay validation.